DOI: 10.12890/2024_004283

Acute thrombocytosis in a patient treated with ertapenem

Authors

  • Edward K. Sarfo Icahn School of Medicine at Mount Sinai, New York, USA
  • Jennifer L. Dziemianko Icahn School of Medicine at Mount Sinai, New York, USA; NYC Health and Hospitals, Elmhurst Hospital Center, New York, USA
  • Thomas Chen Icahn School of Medicine at Mount Sinai, New York, USA
  • Kosuke K. Iwaki Icahn School of Medicine at Mount Sinai, New York, USA; NYC Health and Hospitals, Elmhurst Hospital Center, New York, USA

dziemiaj@nychhc.org

Keywords

ertapenem, thrombocytosis

Abstract

Ertapenem, a carbapenem-type beta-lactam antibiotic, demonstrates broad-spectrum efficacy against a wide range of Gram-positive and Gram-negative bacteria, including aerobes and anaerobes. Importantly, it demonstrates resistance to virtually all beta-lactamases, including the extended spectrum beta-lactamases (ESBLs). Haematologic complications such as thrombocytosis, haemolysis, anaemia, and neutropenia are infrequent side effects associated with this drug. In this report, we present a rare case of ertapenem-induced thrombocytosis in a 62-year-old female patient who was admitted for a complicated urinary tract infection caused by Escherichia coli.

View the entire article

Downloads

References

  1. Zhanel GG, Johanson C, Embil JM, Noreddin A, Gin A, Vercaigne L, et al. Ertapenem: review of a new carbapenem. Expert Rev Anti infect Ther 2005;3:23–39.
  2. Schafer AI. Thrombocytosis. N Engl J Med 2004;350:1211–1219.
  3. Docobo RA, Bukhari S, Qutrio Baloch Z. Ertapenem-induced thrombocytosis. Cureus 2017;9.
  4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.

Published

2024-01-25

Issue

Vol. 11 No. 2 (2024)

Categories

How to Cite

1.
Sarfo EK, Dziemianko JL, Chen T, Iwaki KK. Acute thrombocytosis in a patient treated with ertapenem. EJCRIM [Internet]. 2024 Jan. 25 [cited 2026 Nov. 3];11(2). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4283